Trials / Conditions / Hemoglobin SC Disease

Hemoglobin SC Disease

10 registered clinical trials studyying Hemoglobin SC Disease.

Status	Trial	Sponsor	Phase
Terminated	Treatment of Adult Patients With Hemoglobin SC Disease (SCYTHE) NCT02640573	Baylor College of Medicine	Phase 2
Terminated	Treatment of Hemoglobin SC Disease With Hydroxyurea NCT02336373	Baylor College of Medicine	Phase 2
Withdrawn	Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis NCT01925001	Sangart	Phase 2
Completed	Safety Study of MP4CO in Adult Sickle Cell Patients NCT01356485	Sangart	Phase 1
Completed	Parent Educational Program for Children With Sickle Cell Disease NCT00860782	University of Miami	N/A
Completed	Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease NCT00600665	University of Illinois at Chicago	N/A
Terminated	Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease NCT00532883	St. Jude Children's Research Hospital	Phase 2
Terminated	Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia NCT00034528	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Terminated	Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate NCT00040456	Baylor College of Medicine	Phase 2
Completed	A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disor NCT00005783	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 1